<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/18114" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/18114/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/18114/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_18114"><akn:num>18114</akn:num><akn:heading>Access to therapies</akn:heading><akn:content><akn:p>§ 18114. Access to therapies
Notwithstanding any other provision of this Act, the Secretary of Health and Human Services shall not promulgate any regulation that—(1) creates any unreasonable barriers to the ability of individuals to obtain appropriate medical care;

(2) impedes timely access to health care services;

(3) interferes with communications regarding a full range of treatment options between the patient and the provider;

(4) restricts the ability of health care providers to provide full disclosure of all relevant information to patients making health care decisions;

(5) violates the principles of informed consent and the ethical standards of health care professionals; or

(6) limits the availability of health care treatment for the full duration of a patient’s medical needs.

(Pub. L. 111–148, title I, § 1554, Mar. 23, 2010, 124 Stat. 259.)

Editorial Notes

References in TextThis Act, referred to in text, is Pub. L. 111–148, Mar. 23, 2010, 124 Stat. 119, known as the Patient Protection and Affordable Care Act. For complete classification of this Act to the Code, see Short Title note set out under section 18001 of this title and Tables.</akn:p></akn:content><akn:subsection eId="subsec_18114_1"><akn:num>(1)</akn:num><akn:content><akn:p>(1) creates any unreasonable barriers to the ability of individuals to obtain appropriate medical care;</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_18114_2"><akn:num>(2)</akn:num><akn:content><akn:p>(2) impedes timely access to health care services;</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_18114_3"><akn:num>(3)</akn:num><akn:content><akn:p>(3) interferes with communications regarding a full range of treatment options between the patient and the provider;</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_18114_4"><akn:num>(4)</akn:num><akn:content><akn:p>(4) restricts the ability of health care providers to provide full disclosure of all relevant information to patients making health care decisions;</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_18114_5"><akn:num>(5)</akn:num><akn:content><akn:p>(5) violates the principles of informed consent and the ethical standards of health care professionals; or</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_18114_6"><akn:num>(6)</akn:num><akn:content><akn:p>(6) limits the availability of health care treatment for the full duration of a patient’s medical needs.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>